CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(12): E1900-E1908
DOI: 10.1055/a-1594-1833
Original article

Quality management system for screening esophagogastroduodenoscopy improves detection of Helicobacter pylori-negative interval gastric cancer

Fumiaki Ishibashi
1   Koganei Tsurukame Clinic, Endoscopy Center, Tokyo, Japan
2   Shinjuku Tsurukame Clinic, Digestive Disease Center, Tokyo, Japan
,
Konomi Kobayashi
1   Koganei Tsurukame Clinic, Endoscopy Center, Tokyo, Japan
,
Tomohiro Kawakami
1   Koganei Tsurukame Clinic, Endoscopy Center, Tokyo, Japan
,
Ryu Tanaka
2   Shinjuku Tsurukame Clinic, Digestive Disease Center, Tokyo, Japan
,
Kazuaki Sugihara
2   Shinjuku Tsurukame Clinic, Digestive Disease Center, Tokyo, Japan
3   Mirraza Shinjuku Tsurukame Clinic, Tokyo, Japan
,
Satoshi Baba
2   Shinjuku Tsurukame Clinic, Digestive Disease Center, Tokyo, Japan
4   Yotsuya Medical Cube, Endoscopy Center, Tokyo, Japan
› Author Affiliations

Abstract

Background and study aims Double-checking the findings of examinations is necessary for endoscopy quality control in gastric cancer screening; however, there have been no reports showing its effectiveness. We prospectively analyzed the effectiveness of a quality management system (QMS) in endoscopy for gastric cancer screening.

Patients and methods QMS was defined as having images and reports checked by a second endoscopist on the same day and reporting inconsistencies to the examining endoscopist. Patients diagnosed with early gastric cancer (EGC) in the 2 years before and after the introduction of QMS were divided into two groups: the interval cancer group, which included those for whom cancer was detected within 1 year of the last endoscopy and the noninterval cancer group. Changes in detection rates were compared.

Results Before the introduction of QMS, 11 interval EGC cases were diagnosed among 36,189 endoscopies, whereas after the introduction, 32 interval ECG cases were diagnosed among 38,290 endoscopies (P = 0.004). Fifteen noninterval EGC cases were diagnosed before the introduction, while 12 noninterval EGC cases were diagnosed after the introduction; no significant difference was observed. Subanalyses by Helicobacter pylori (HP) infection status revealed no difference in the detection rate among HP-positive EGC patients, but the detection rates among HP-eradicated and HP-naïve EGC patients were improved (P = 0.005 and P = 0.011). Logistic regression analysis showed that QMS was an independent predictor for detection of HP-negative interval EGC (P = 0.017, OR = 4.4, 95 % CI: 2.0–9.7).

Conclusions QMS improved the detection rate for HP-negative interval early gastric cancer. (UMIN000042991)



Publication History

Received: 05 May 2021

Accepted: 13 August 2021

Article published online:
14 December 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Hamashima C, Ogoshi K, Okamoto M. et al. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One 2013; 8: e79088-e79096
  • 2 Hamashima C, Shabana M, Okada K. et al. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci 2015; 106: 1744-1749
  • 3 Hosokawa O, Miyanaga T, Kaizaki Y. et al. Decreased death from gastriccancer by endoscopic screening: association with a population-based can-cer registry. Scand J Gastroenterol 2008; 43: 1112-1115
  • 4 Jun JK, Choi KS, Lee HY. et al. Effectiveness of the Korean national cancerscreening program in reducing gastric cancer mortality. Gastroenterology 2017; 152: 1319-1328
  • 5 Noh CH, Lee E, Lee GH. et al. Association of intensive endoscopic screening burden with gastric cancer detection. JAMA Netw Open 2021; 4: e2032542
  • 6 Yao K, Uedo N, Kamada T. et al. Guidelines for endoscopic diagnosis of early gastric cancer. Dig Endosc 2020; 32: 663-698
  • 7 Evans JA, Chandrasekhara V, Chathadi KV. ASGE Standards of Practice Committee. et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc 2015; 82: 1-8
  • 8 Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Jpn J Clin Oncol 2018; 48: 278-286
  • 9 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803
  • 10 Rex DK, Petrini JL, Baron TH. et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006; 63: S16-S28
  • 11 Barclay RL, Vicari JJ, Doughty AS. et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006; 355: 2533-2541
  • 12 Butterly L, Robinson CM, Anderson JC. et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 2014; 109: 417-426
  • 13 Shaukat A, Rector TS, Church TR. et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology 2015; 149: 952-957
  • 14 Lim S, Hammond S, Park J. et al. Training interventions to improve adenoma detection rates during colonoscopy: a systematic review and meta-analysis. Surg Endosc 2020; 34: 3870-3882
  • 15 Ishibashi F, Fukushima K, Kobayashi K. et al. Individual feedback and monitoring of endoscopist performance improves the adenoma detection rate in screening colonoscopy: a prospective case-control study. Surg Endosc 2020; 35: 2566-2575
  • 16 Teh JL, Tan JR, Lau LJ. et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015; 13: 480-487
  • 17 Kawamura T, Wada H, Sakiyama N. et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc 2017; 29: 569-575
  • 18 Park JM, Huo SM, Lee HH. et al. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenterology 2017; 153: 460-469
  • 19 Januszewicz W, Wieszczy P, Bialek A. et al. The endoscopists’ biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation. Gastrointest Endosc 2019; 89: 1141-1149
  • 20 Ishibashi F, Kobayashi K, Fukushima K. et al. Quality indicators for the detection of Helicobacter pylori-negative early gastric cancer: a retrospective observational study. Clin Endosc 2020; 53: 698-704
  • 21 Khalil Q, Gopalswamy N, Agrawal S. Missed esophageal and gastric cancers after esophagogastroduodenoscopy in a midwestern military veteran population. South Med J 2014; 107: 225-228
  • 22 Pimenta-Melo AR, Monteiro-Soares M, Libanio D. et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2016; 28: 1041-1049
  • 23 Park MS, Yoon JY, Chung HS. et al. Clinicopathologic characteristics of interval gastric cancer in Korea. Gut Liver 2015; 9: 167-173
  • 24 Choi KS, Jun JK, Park EC. et al. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One 2012; 7: e50041
  • 25 R Core Team. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
  • 26 Sato C, Hirasawa K, Tateishi Y. et al. Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients. World J Gastroenterol 2020; 26: 2618-2631
  • 27 Nishizawa T, Suzuki H, Arano T. et al. Characteristics of gastric cancer detected within 1 year after successful eradication of Helicobacter pylori . J Clin Biochem Nutr 2016; 59: 226-230
  • 28 Ueyama H, Matsumoto K, Nagahara A. et al. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2014; 46: 153-157
  • 29 Ishibashi F, Fukushima K, Ito T. et al. Influence of Helicobacter pylori Infection on endoscopic findings of gastric adenocarcinoma of the fundic gland type. J Gastr Cancer 2019; 19: 225-233
  • 30 Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer 2016; 19: 524-530
  • 31 Shimodate Y, Mizuno M, Doi A. et al. Gastric superficial neoplasia: high miss rate but slow progression. Endosc Int Open 2017; 5: E722-E726